At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults
Launched by EYEQUE CORP. · Mar 24, 2021
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
This study is aimed at examining the BCVA from try-on glasses constructed from measurements from the EyeQue VisionCheck. The refraction measurements that users obtain from the VisionCheck are from testing at-home and without additional guidance other than that normally provided to those purchasing the device.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or Female
- • 2. Ages 30+
- • 3. Had purchased an EyeQue refraction device.
- • 4. Obtained EGN's from the EyeQue refraction device.
- • 5. Ordered Try-On glasses based on EyeQue EyeGlass Numbers.
- • 6. Allow use for this study the VisionCheck refraction and try-on glasses measurements, taken prior to study participation.
- Subject Exclusion Criteria, Subjects that by self-report:
- • 1. Do not have a command of the English language.
- • 2. Lack the ability to follow instructions.
- • 3. Lack binocular vision.
- • 4. Are Color-blind.
About Eyeque Corp.
EyeQue Corp. is a pioneering healthcare technology company dedicated to advancing vision care through innovative, user-friendly solutions. Specializing in the development of portable vision testing devices and telehealth applications, EyeQue empowers individuals to monitor and manage their eye health from the comfort of their homes. By leveraging cutting-edge technology and data analytics, the company aims to enhance accessibility to vision care, improve patient outcomes, and contribute to the growing field of telemedicine. Through its commitment to research and clinical trials, EyeQue is at the forefront of transforming how vision impairment is detected and treated.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, California, United States
Patients applied
Trial Officials
Noam Sapiens, PhD
Principal Investigator
EyeQue Corporation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials